Alaunos Therapeutics share price logo

Alaunos Therapeutics

NASDAQ: TCRT

$1.98

+0.05

(+2.59%)

as on

Alaunos Therapeutics Stock Performance

as on August 18, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.85
    $2.00
    downward going graph

    6.57%

    Downside

    1.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.67
    $4.59
    downward going graph

    15.66%

    Downside

    131.82%

    Upside

    downward going graph

Alaunos Therapeutics share price movements today

Previous Close
$1.93
Open
$2.00
Volume
112.2K
Market Cap
$4.7M
Day's Low - High
$1.85 - $2.00
52 Week Low - High
$1.67 - $4.59

Alaunos Therapeutics Historical Returns

1 Month Return
-5.85 %
3 Month Return
-21.86 %
1 Year Return
-14.22 %
3 Year Return
-90.19 %
5 Year Return
0 %

Alaunos Therapeutics Stock Fundamentals & Key Indicators

Check Alaunos Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.7M

EPS (TTM)

-2.17

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.92

Industry PE ratio

-1.5966015625

PEG Ratio

-0.05635054178086544

EBITDA

-4.1M

Revenue (TTM)

3.0K

Profit Margin

-34000.00%

Return On Equity TTM

-165.94%

Alaunos Therapeutics Stock Valuation

Track how Alaunos Therapeutics P/E has moved over time to understand its valuation trends.

Alaunos Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-3.74x)

December 31, 2022

Industry (-1.60x)

December 31, 2025

Today (-1.47x)

December 31, 2025

Highest (-0.48x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -1.47x

Alaunos Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alaunos Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
SELL$4.7MNA-0.92-34000.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Alaunos Therapeutics Stock including INR - Dollar returns

The Alaunos Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Alaunos Therapeutics investment value today

Current value as on today

₹96,346

Returns

-₹3,654

(-3.65%)

Returns from Alaunos Therapeutics Stock

-₹12,000 (-12%)

Dollar Impact

₹8,346 (+8.35%)

Analyst Recommendation on Alaunos Therapeutics Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Alaunos Therapeutics. Average target price of $1.75

Alaunos Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Alaunos Therapeutics.

What analysts predicted

-13.14%DOWNSIDE

Target Price

$1.75

Current Price

$1.98

Analyzed by

6 Analysts

Target

$1.75

Alaunos Therapeutics target price $1.75, a slight downside of -13.14% compared to current price of $1.98. According to 6 analysts rating.

Indian Investors' Interest in Alaunos Therapeutics Stock

Search interest for Alaunos Therapeutics Stock has increased by 87% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:87% versus previous 30 day period

Alaunos Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
-
0
0
-
-
0
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-7
-1
-1
-1
0
-1
-1
-1
0
-1
EBITDA
-3
-1
-1
-1
0
-1
-1
-1
0
0
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
-
0
-
0
-
0
0
Income Before Tax
-7
-1
-1
-1
0
-1
-1
-1
0
-1
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-7
-1
-1
-1
0
-1
-1
-1
0
-1
Net Profit Margin
-93200.00%
-100.00%
-4400.00%
0.00%
100.00%
-17250.00%
0.00%
0.00%
-11933.33%
0.00%

Alaunos Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
6
0
-
-
0
2
0
0
0
Gross Profit
6
0
0
-1
-46
-19
-4
0
-1
Operating Income
-53
-53
-57
-80
-77
-35
-34
-4
-4
EBITDA
-53
-53
-117
-78
-74
-31
-30
-4
-4
Interest Expense
0
-
-
-
1
3
1
-
-
Depreciation
0
0
0
1
2
2
2
0
0
Income Before Tax
-54
-53
-117
-79
-78
-37
-35
-4
-4
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-54
-53
-117
-79
-78
-37
-35
-4
-4
Net Profit Margin
100.00%
100.00%
0.00%
0.00%
100.00%
100.00%
-95960.00%
100.00%
-27160.00%

Alaunos Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-7
-1
-1
-1
0
-1
-1
-1
0
-1
Operating Cash Flow
-7
-1
-1
0
0
0
0
0
0
-1
Investing Cash Flow
1
-
-
-
-
-
-
0
0
-
Financing Cash Flow
-
-
-
-
-
-
3
-
-
-
Change in Cash
-5
-1
-1
0
0
0
2
0
0
-1

Alaunos Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-54
-53
-117
-79
-78
-37
-35
-4
-4
Operating Cash Flow
-54
-49
-40
-57
-61
-29
-30
-4
-2
Investing Cash Flow
0
0
0
-9
-3
0
1
-
0
Financing Cash Flow
45
40
59
102
25
6
-18
-
3
Change in Cash
-10
-9
18
35
-39
-23
-46
-4
0

Mutual Funds that own Alaunos Therapeutics Stock

Check out the Mutual Funds with significant holdings in Alaunos Therapeutics.

Funds
Holdings
Shares Held
Victory Portfolios III
0.992651%
24242
Fidelity Concord Street Trust
0.748317%
18275
VANGUARD INDEX FUNDS
0.575845%
14063

Global Institutional Holdings in Alaunos Therapeutics

Funds
Holdings
Vanguard
0.58%

Insights on Alaunos Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 2.0K → 3.0K (in $), with an average increase of 33.3% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -1.00M → -952.0K (in $), with an average increase of 5.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 458.9% return, outperforming this stock by 476.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 587.7% return, outperforming this stock by 677.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, TCRT stock has moved down by -89.6%

About Alaunos Therapeutics

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
OrganisationAlaunos Therapeutics
Headquarters501 E. Las Olas Blvd., Fort Lauderdale, FL, United States, 33301
IndustryBiotechnology
CEOMr. Holger Weis CPA
E-voting on sharesClick here to vote

Key Management of Alaunos Therapeutics

Name

Title

Mr. Holger Weis CPA

Chairman of the Board & CEO

Mr. Ferdinand Groenewald

Vice President of Finance & Corporate Secretary

FAQs

What is Alaunos Therapeutics share price today?

Alaunos Therapeutics share price today is $1.98 as on at the close of the market. Alaunos Therapeutics share today touched a day high of $2.00 and a low of $1.85.

What is the 52 week high and 52 week low for Alaunos Therapeutics share?

Alaunos Therapeutics share touched a 52 week high of $4.59 on and a 52 week low of $1.67 on . Alaunos Therapeutics stock price today i.e. is closed at $1.98,which is 56.86% down from its 52 week high and 18.56% up from its 52 week low.

What is Alaunos Therapeutics's market capitalisation today?

Alaunos Therapeutics market capitalisation is $0.00T as on .

How to invest in Alaunos Therapeutics Stock (TCRT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alaunos Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Alaunos Therapeutics Shares that will get you 0.7576 shares as per Alaunos Therapeutics share price of $1.98 per share as on August 18, 2026 at 1:29 am IST.

What is the minimum amount required to buy Alaunos Therapeutics Stock (TCRT) from India?

Indian investors can start investing in Alaunos Therapeutics (TCRT) shares with as little as ₹95.592 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.92 in Alaunos Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Alaunos Therapeutics share’s latest price of $1.98 as on August 18, 2026 at 1:29 am IST, you will get 5.0505 shares of Alaunos Therapeutics. Learn more about fractional shares .